600 reports

The global vaccines market (including COVID-19 vaccines) is projected to reach USD 149.2billion by 2026 from USD 139.4 billion in 2021 during the forecast period. The global vaccines market (excluding COVID-19 vaccines) is projected to reach USD 67.2billion by 2026 from USD 41.4 billion in 2021, at a CAGR of 10.2% from 2021 to 2026. Market...

  • Infectious Disease
  • Vaccine
  • World
  • Europe
  • North America
  • APAC
  • Drug Approval
  • Vaccination Coverage

The virus like particles (VLP’s) market is projected to reach US$ 7,858.82 million by 2028 from US$ 4,601.84 million in 2021; it is expected to grow at a CAGR of 7.9% from 2021 to 2028. Consistent R&D activities prominently drive the growth of the overall market. VLPs have gained attention from many researchers, particularly virologists and...

  • Vaccine
  • World
  • HIV AIDS Prevalence
  • HIV Incidence

China’s demand for Vaccines has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and...

  • Vaccine
  • China
  • Vaccine Import
  • Industrial Production

The vaccine adjuvants market was valued at approximately USD 665.86 million in 2020, and it is expected to witness a revenue of USD 1478.32 million in 2026, with a CAGR of 13.37% over the forecast period, 2021-2026. During the COVID-19 pandemic, as the import and export activities have been restricted due to the lockdown, it is expected...

  • Vaccine
  • World
  • Health Expenditure
  • Vaccination Coverage

The global pneumococcal vaccine market is estimated to be USD 7,820.88 million in 2021. It is expected to reach USD 10,177 million by 2027, registering a CAGR of 4.61% from 2022 to 2027. The major factor attributing to the growth of the market increasing the prevalence of pneumococcal contaminations. This pandemic had a dramatic effect...

  • Vaccine
  • World
  • Vaccination Coverage
  • Child Immunisation Coverage

RSV, or respiratory syncytial virus, is a common respiratory virus that causes mild, cold-like symptoms in both the upper and lower respiratory tracts. RSV can be harmful, especially in infants and the elderly, even though most individuals recover in a week or two. According to the Cleveland Clinic, RSV affects around 57,000 children under...

  • Vaccine
  • World
  • Health Expenditure
  • Urban Population

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Vaccine Storage and Packaging Market Report The Vaccine Storage and Packaging market was valued at USD 3,544.28 million in 2020 and is expected to reach USD 5,661.25 million by 2026 growing at a CAGR of 8.12% The following factors are...

  • Packaging
  • Vaccine
  • World
  • Cause-Specific Mortality Rate
  • Vaccination Coverage

The travel vaccines market is projected to reach US$ 5,914.22 million by 2028 from US$ 3,078.94 million in 2021. It is estimated to grow at a CAGR of 9.8% from 2021 to 2028. The report highlights trends prevailing in the travel vaccines market and factors driving the travel vaccines market growth.The travel vaccines market growth is...

  • Vaccine
  • World
  • Europe
  • APAC
  • Middle East
  • Africa
  • Tourist Arrivals
  • Infectious Disease Prevalence

Typhoid Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Typhoid Fever - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides...

  • Vaccine
  • World
  • India
  • Medical Technology Density

The travel vaccines market is projected to reach US$ 5,914.22 million by 2028 from US$ 3,078.94 million in 2021; it is estimated to grow at a CAGR of 9.8% from 2021 to 2028. Travelling and tourism have become an integral part of the human lifestyle.Travelling and tourism has not only transformed the ongoing routine of people but also...

  • Vaccine
  • World
  • Europe
  • APAC
  • Tourist Arrivals
  • Infectious Disease Incidence

Streptococcus pyogenes Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Streptococcus pyogenes Infections - Drugs in Development by Stages, Target, MoA, RoA, Molecule...

  • Pharmaceutical
  • Vaccine
  • Drug Development
  • World
  • Mortality Rate
  • Cause-Specific Mortality Rate

Cholera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cholera - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview...

  • Vaccine
  • Infectious Disease
  • World
  • Infectious Disease Prevalence
  • Child Mortality

Executive Summary The mRNA technology finds its applications in many diseases including the Covid-19 vaccine. The market for mRNA is mostly driven by the Covid-19 vaccine besides its major usage in cancer therapies. With the mutation of the coronavirus and possible spread of variants of the virus, the mRNA companies are...

  • Therapy
  • Vaccine
  • World
  • APAC
  • Health Expenditure
  • Urban Population

The global plant-based vaccines market is expected to reach US$ 2,672.05 million by 2028 from US$ 1,143.72 million in 2021, growing at a CAGR of 12.9 % from 2021 to 2028. Increasing research & development (R & R&D) activities and the growing prevalence of infectious diseases are fueling the market’s growth. However, the potential risk of...

  • Infectious Disease
  • Vaccine
  • World
  • APAC
  • Middle East
  • Health Expenditure
  • Mortality Rate

The global influenza vaccines market is projected to exceed US$ 9.5 Billion mark by 2027, and is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets,...

  • Vaccine
  • World
  • Vaccination Coverage
  • Health Expenditure

Pediatric Vaccine Global Market Opportunities And Strategies To 2030: COVID 19 Growth And Change provides the strategists, marketers and senior management with the critical information they need to assess the global pediatric vaccine market as it emerges from the COVID 19 shut down. Description: Where is the largest...

  • Vaccine
  • World
  • Health Expenditure
  • Gross Domestic Product Per Capita

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Vaccine Contract Manufacturing Market Report The global vaccine contract manufacturing market by revenue is expected to grow at a CAGR of approx. 13% during the period 2020–2026. The global vaccine contract manufacturing market has...

  • Vaccine
  • World
  • Vaccination Coverage
  • Cause-Specific Mortality Rate

Executive Summary Global Covid-19 vaccine Market will be valued at approximately USD 25 billion in the year 2024. The growing government support for vaccine development and the increasing involvement of global organizations in the development of adequate vaccination facilities in endemic regions is anticipated to positively...

  • Vaccine
  • Infectious Disease
  • World
  • Health Expenditure
  • Private Health Expenditure

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Covid-19 Vaccine Market Report The global COVID-19 vaccine market by revenue is expected to reach a value of USD 5 billion during 2021–2024. VACCINE PIPELINE INSIGHTS The global COVID-19 vaccine market size is...

  • Vaccine
  • Infectious Disease
  • World
  • Europe
  • North America
  • Latin America
  • Mortality Rate
  • Cause-Specific Mortality Rate

Plague Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Plague - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview...

  • Vaccine
  • Infectious Disease
  • World
  • Medical Technology Density

Typhoid Fever (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Typhoid Fever - Drugs in Development, 2021, provides an overview of the Typhoid Fever (Infectious Disease) pipeline landscape. Typhoid fever is an infection...

  • Vaccine
  • World
  • India

The vaccines market was valued at US$ 39,128.3 million in 2019 and is projected to reach US$ 64,538.4 million by 2027; it is expected to grow at a CAGR of 6.5% from 2020 to 2027.The major driving factors are rising prevalence of infectious diseases, growing focus on immunization programs, and increasing support for vaccine development are...

  • Infectious Disease
  • Vaccine
  • World
  • APAC
  • Health Expenditure
  • Vaccination Coverage

INTRODUCTION Unlike the prophylactic vaccines that are designed and administered as a precautionary measure to prevent the occurrence of a disease, researchers have developed therapeutic vaccines intended to alleviate the suffering of patients already infected with the disease. Therapeutic vaccines are not as efficacious...

  • Vaccine
  • World
  • APAC
  • Europe
  • North America

Major players in the vaccine market are AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck, Pfizer, Sanofi Pasteur, Abbott, Astellas Pharma, Bavarian Nordic, CSL Limited, Daiichi Sankyo Company, Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India, Takeda Pharmaceutical Co. Ltd., Biological E Limited, BiondVax...

  • Vaccine
  • World
  • United States

Warts Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Warts - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview...

  • Dermatological Condition
  • Pharmaceutical
  • Vaccine
  • Biotechnology
  • World
  • China
  • Drug Approval
  • Electric Vehicle Sales

Streptococcus pyogenes Infections (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Streptococcus pyogenes Infections - Drugs in Development, 2021, provides an overview of the Streptococcus pyogenes Infections (Infectious Disease)...

  • Pharmaceutical
  • Therapy
  • Vaccine
  • Drug Development
  • World

INTRODUCTION As per recent estimates (reported in May 2022), more than 11.6 billion doses of COVID-19 vaccines have been administered across 184 countries; this value roughly translates to 20.9 million doses per day. Vaccines have enabled the prevention of more than 37 million deaths due to various disease indications,...

  • Vaccine
  • World
  • APAC
  • Europe
  • North America
  • Cause-Specific Mortality Rate

Global Vaccines Market 2022-2026 The analyst has been monitoring the vaccines market and it is poised to grow by $ 28.28 bn during 2022-2026, accelerating at a CAGR of 4.13% during the forecast period. Our report on the vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges,...

  • Vaccine
  • World

Major players in the DTP vaccines market are Merck & Co., Sanofi, GSK, Lanzhou Institute of Biological Products, Novartis AG, Pfizer Inc., Johnson & Johnson, Seqirus, AJ Vaccines and Bionet-Asia. The global DTP vaccines market is expected to grow from $4.00 billion in 2021 to $4.45 billion in 2022 at a compound annual growth rate (CAGR)...

  • Infectious Disease
  • Vaccine
  • World
  • India

Human Papillomavirus Minor Capsid Protein L2 (L2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Human Papillomavirus Minor Capsid Protein L2 (L2) - L2 is a minor capsid component and lacks the capacity to form VLPs. This protein...

  • Vaccine
  • World
  • Vaccination Coverage